BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Elsunersen readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Elsunersen\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07019922-8868@assetmemo.bio
DTSTAMP:20261121T004026Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Elsunersen: Phase 3 readout est. (NCT07019922)
DESCRIPTION:Elsunersen\, phase 3\, Epilepsy.\nStudy: A Clinical Trial of El
 sunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety\nEstimated p
 rimary completion: December 2026. This is a ClinicalTrials.gov estimate\, 
 not a confirmed readout date\, and it can move.\nDrug page: https://assetm
 emo.bio/drug/elsunersen#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT07019922
URL:https://assetmemo.bio/drug/elsunersen#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
